Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 38Neoplasms 33Depression 28Fatigue 24Prostatic Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 17Multiple Myeloma 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 14Burkitt Lymphoma 14Lymphoma, B-Cell, Marginal Zone 13Leukemia, Myeloid, Acute 13Hodgkin Disease 13Colorectal Neoplasms 13Lymphoma, Large-Cell, Immunoblastic 12Lung Neoplasms 12Anxiety Disorders 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Blast Crisis 11Leukemia, Myeloid, Accelerated Phase 10Recurrence 9Pain 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Leukemia, Hairy Cell 9Leukemia 9

Interventions

padeliporfin 5pembrolizumab 1palladium-bacteriopheophorbide 1ixabepilone 1Therapeutics 1Radiotherapy 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Ipilimumab 1Gemcitabine 1Cisplatin 1Chemical Fractionation 1Biopsy, Needle 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Genital Neoplasms, Male × Therapeutics × Clear all
NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Steba Biotech S.A.

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡